טוען...
Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
Proton pump inhibitors are the one of the most widely used drugs in the world. Hypomagnesemic hypoparathyroidism has been reported with different proton pump inhibitors with prolonged oral use. We report the first reported case of possible such effect with intravenous preparation of proton pump inhi...
שמור ב:
| הוצא לאור ב: | Indian J Pharmacol |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4450563/ https://ncbi.nlm.nih.gov/pubmed/26069375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.157135 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|